Research and Markets: Advances in Tissue Engineering and Organ Regeneration (Technical Insights)

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/bkzpml/advances_in) has announced the addition of the "Advances in Tissue Engineering and Organ Regeneration (Technical Insights)" report to their offering.

Tissue engineering, which is now being categorized as a form of regenerative medicine, can be defined as biomedical engineering to reconstruct, repair, and improve biological tissues. Research efforts in tissue engineering have been ongoing and it is emerging as one of the key areas of medical research.

Furthermore, there are vast developments in tissue engineering, which involve leveraging of technologies from biomaterials, molecular medicine, biochemistry, nanotechnology, genetic and biomedical engineering for regeneration and cell expansion targets to restructure and/or repair human organs.

Tissue engineering is often referred to as regenerative medicine and reparative medicine. It is an interdisciplinary field requiring the combined efforts of cell biologists, engineers, material scientists, geneticists, clinicians, mathematicians etc., towards the development of biological substitutes that restore, maintain, or improve tissue function. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement.

Cells placed on or within the tissue constructs is the most common methodology in tissue engineering. Successful cell seeding as it is known depends on the fast attachment of engineered cell to scaffolds, high cell survival and uniform cell distribution over the scaffold. The cell seeding time is dependents strongly on the scaffold material and structure. Scaffolds act as an initial biochemical substrate for the new cells to proliferate, until the cells can produce their own extra-cellular matrix (ECM).

Tissue engineering has been a field of consistent research for just more than a decade. Still considered a nascent science, research in the field has offered and continues to offer an increasing number of substitutes for applications that would enable the human body to withstand pain and injuries inflicted upon it. While in the present time, it is a task to categorize tissue engineering into their respective categories, applications so far have been developed across three fronts namely materials, biomolecules, and cells.

In brief this study provides:

- A brief snapshot of the capabilities of existing technologies and standards in the tissue engineering and organ regeneration domain.

- An overview of the value chain networks existing in this domain and the assessment of the value chain networks.

- A sneak preview of the market impact of key innovations in this segment.

- A brief snapshot on the key business accelerators and challenges in the tissue engineering and organ regeneration domain.

- A brief snapshot on the demands from the end-user side.

Key Topics Covered:

1. Executive Summary

2. Technology Snapshot and Trends

3. Technology Capability

4. Impact Assessment and Analysis

5. Diffusion of Innovations and Needs Assessment

6. Opportunity Evaluation and Roadmapping

7. Key Contacts and Patents

8. Decision Support Database

For more information visit http://www.researchandmarkets.com/research/bkzpml/advances_in

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals